Haleon PLC

HLN

Company Profile

  • Business description

    Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

  • Contact

    The Heights
    Building 5, First Floor
    Surrey
    WeybridgeKT13 0NY
    GBR

    T: +44 1932959500

    E: [email protected]

    https://www.haleon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    24,622

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,768.601.60-0.02%
CAC 407,843.4338.760.50%
DAX 4024,370.5994.110.39%
Dow JONES (US)42,427.7491.90-0.22%
FTSE 1008,826.2124.920.28%
HKSE23,906.97252.941.07%
NASDAQ19,460.4961.530.32%
Nikkei 22537,554.49192.96-0.51%
NZX 50 Index12,577.1582.440.66%
S&P 5005,970.810.440.01%
S&P/ASX 2008,538.902.90-0.03%
SSE Composite Index3,384.107.900.23%

Market Movers